arrow
Back
J

Johanna C. Bendell

roche holding

82H-index
928Paper Count
3.0WCitation Count
Published Papers 160
Publication Date
First Results of Migoprotafib, a Potent and Highly Selective Src Homology-2 Domain-Containing Phosphatase 2 Inhibitor in Patients with Advanced Solid Tumors
err2024-12-31
err0
errOAAI
errJohnson, Melissa L.; Wolf, Beni B.; Wang, Judy S.; Philipovskiy, Alexander; Shapiro, Geoffrey I.; Bockorny, Bruno; Guo, Wei; Shen, Jinshan; Jen, Kai Yu; Lerose, Marybeth; Hunter, Tamieka Lauz; Padval, Mahesh; Schmidt-Kittler, Oleg; Bhatia, Namrata; Dubey, Sarita; Suchomel, Julia; Bendell, Johanna C.; Jauhari, Shekeab; Eng-Wong, Jennifer; Lin, Jessica J.
errShare
errSave
Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer
err2023-09-23
err10
errOAAI
errTaraborrelli, Lucia; Senbabaoglu, Yasin; Wang, Lifen; Lim, Junghyun; Blake, Kerrigan; Kljavin, Noelyn; Gierke, Sarah; Scherl, Alexis; Ziai, James; Mcnamara, Erin; Owyong, Mark; Rao, Shilpa; Calviello, Aslihan Karabacak; Oreper, Daniel; Jhunjhunwala, Suchit; Argiles, Guillem; Bendell, Johanna; Kim, Tae Won; Ciardiello, Fortunato; Wongchenko, Matthew J.; de Sauvage, Frederic J.; Melo, Felipe; Yan, Yibing; West, Nathaniel R.; Murthy, Aditya
errShare
errSave
Predictive potential of angiopoietin-2 in a mCRC subpopulation treated with vanucizumab in the McCAVE trial
err2023-05-03
err5
errOAAI
errFerreira, Claudia S.; Babitzki, Galina; Klaman, Irina; Krieter, Oliver; Lechner, Katharina; Bendell, Johanna; Harring, Suzana Vega; Heil, Florian
errShare
errSave
Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors
err2023-04-22
err9
errOAAI
errLuke, Jason J.; Fakih, Marwan; Schneider, Charles; Chiorean, E. Gabriela; Bendell, Johanna; Kristeleit, Rebecca; Kurzrock, Razelle; Blagden, Sarah P.; Brana, Irene; Goff, Laura W.; O'Hayer, Kevin; Geschwindt, Ryan; Smith, Michael; Zhou, Feng; Naing, Aung
errShare
errSave
Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study
err2023-03-01
err17
PREAI
errShah, Manish A.; Yoshino, Takayuki; Tebbutt, Niall C.; Grothey, Axel; Tabernero, Josep; Xu, Rui-Hua; Cervantes, Andres; Oh, Sang Cheul; Yamaguchi, Kensei; Fakih, Marwan; Falcone, Alfredo; Wu, Christina; Chiu, Vi K.; Tomasek, Jiri; Bendell, Johanna; Fontaine, Marilyn; Hitron, Matthew; Xu, Bo; Taieb, Julien; Van Cutsem, Eric
errShare
errSave
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920
errCANCER
IF5.1
err2021-11-16
err32
errOAAI
errEmamekhoo, Hamid; Olsen, Mark R.; Carthon, Bradley C.; Drakaki, Alexandra; Percent, Ivor J.; Molina, Ana M.; Cho, Daniel C.; Bendell, Johanna C.; Gordan, Lucio N.; Kalebasty, Arash Rezazadeh; George, Daniel J.; Hutson, Thomas E.; Arrowsmith, Edward R.; Zhang, Joshua; Zoco, Jesus; Johansen, Jennifer L.; Leung, David K.; Tykodi, Scott S.
errShare
errSave
TWT-101: A PHASE 1 STUDY OF THE NOVEL HPK1 INHIBITOR CFI-402411 IN PATIENTS WITH ADVANCED CANCER
err2021-11-10
err6
errOAAI
errHamid, Omid; Bendell, Johanna; Fu, Siqing; Papadopoulos, Kyriakos; Wang, Judy; Ma, Brigette; Spreafico, Anna; Spira, Alexander; Bray, Mark; Fletcher, Graham; Michelson, Glenn; Roberts-Thomson, Emily
errShare
errSave
Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels
err2021-10-08
err37
errOAAI
errKurth, Isabel; Yamaguchi, Norihiro; Andreu-Agullo, Celia; Tian, Helen S.; Sridhar, Subhasree; Takeda, Shugaku; Gonsalves, Foster C.; Loo, Jia Min; Barlas, Afsar; Manova-Todorova, Katia; Busby, Robert; Bendell, Johanna C.; Strauss, James; Fakih, Marwan; McRee, Autumn J.; Hendifar, Andrew E.; Rosen, Lee S.; Cercek, Andrea; Wasserman, Robert; Szarek, Michael; Spector, Scott L.; Raza, Syed; Tavazoie, Masoud F.; Tavazoie, Sohail F.
errShare
errSave
Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance)
err2021-10-01
err61
errOAAI
errCohen, R.; Shi, Q.; Meyers, J.; Jin, Z.; Svrcek, M.; Fuchs, C.; Couture, F.; Kuebler, P.; Ciombor, K. K.; Bendell, J.; De Jesus-Acosta, A.; Kumar, P.; Lewis, D.; Tan, B.; Bertagnolli, M. M.; Philip, P.; Blanke, C.; O'Reilly, E. M.; Shields, A.; Meyerhardt, J. A.
errShare
errSave
A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer
err2021-09-24
err15
PREAI
errMoore, Kathleen N.; Hong, David S.; Patel, Manish R.; Pant, Shubham; Ulahannan, Susanna, V; Jones, Suzanne; Meric-Bernstam, Funda; Wang, Judy S.; Aljumaily, Raid; Hamilton, Erika P.; Wittchen, Erika S.; Wang, Xuejing; Lin, Aimee Bence; Bendell, Johanna C.
errShare
errSave
Safety, Efficacy, and Biomarker Results from a Phase Ib Study of the Anti-DKK1 Antibody DKN-01 in Combination with Pembrolizumab in Advanced Esophagogastric Cancers
err2021-09-04
err37
errOAAI
errKlempner, Samuel J.; Bendell, Johanna C.; Villaflor, Victoria Meucci; Tenner, Laura LaNiel; Stein, Stacey M.; Rottman, James B.; Naik, Girish S.; Sirard, Cynthia A.; Kagey, Michael H.; Chaney, Marya F.; Strickler, John H.
errShare
errSave
Phase II study of bavituximab (bavi), a first-in-class antibody targeting phosphatidylserine (PS), plus pembrolizumab (pembro) in advanced gastric or gastroesophageal junction (GEJ) cancer
err2021-09-01
err1
errOAAI
errChau, I.; Culm-Merdek, K.; Bendell, J. C.; Catenacci, D. V.; Lee, J.; Chaney, M. F.; MacIntyre, S.; Gopal, S.; Santos, V. Chamberlain; Youssoufian, H.; Mockbee, C.; Benjamin, L.; Park, H.
errShare
errSave
A phase I/II multicenter, first-in-human study of DS-7300 (B7-H3 DXd-ADC) in patients (pts) with advanced solid tumors
err2021-09-01
err6
errOAAI
errJohnson, M. L.; Doi, T.; Piha-Paul, S. A.; Sen, S.; Shimizu, T.; Cheng, B.; Yoshizuka, N.; Okamoto, N.; Okuda, Y.; Qian, X.; Serbest, G.; Hammett, T.; Brady, W. E.; Patel, M. R.; Bendell, J. C.
errShare
errSave
KRYSTAL-10: A randomized phase 3 study of adagrasib (MRTX849) in combination with cetuximab vs chemotherapy in patients with previously treated advanced colorectal cancer with KRASG12C mutation
err2021-07-01
err14
PREAI
errTabernero, J.; Bendell, J.; Corcoran, R.; Kopetz, S.; Lee, J.; Davis, M.; Christensen, J.; Chi, A.; Kheoh, T.; Yaeger, R.
errShare
errSave
Pembrolizumab vs chemotherapy for MSI-high/dMMR metastatic colorectal cancer: Asia subgroup of phase 3 KEYNOTE-177
err2021-07-01
err1
errOAAI
errYoshino, Takayuki; Kim, Tae Won; Yong, Wei Peng; Shiu, Kai-Keen; Jensen, Benny Vittrup; Jensen, Lars Henrik; Smith, Denis; Garcia-Carbonero, Rocio; Alcaide-Garcia, Julia; Gibbs, Peter; De la Fouchardiere, Christelle; Rivera, Fernando; Elez, Elena; Bendell, Johanna; Le, Dung T.; Yang, Ping; Farooqui, Mohammed; Marinello, Patricia; Diaz, Luis A.; Andre, Thierry
errShare
errSave
Phase Ib study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in patients with metastatic esophageal cancer
err2021-07-01
err14
errOAAI
errWainberg, Z.; Matos, I.; Delord, J.; Cassier, P.; Gil-Martin, M.; Kim, T.; LoRusso, P.; Bahleda, R.; Italiano, A.; Mendus, D.; Hoang, T.; Xue, C.; Wen, X.; Carvalho, O.; Pham, T.; Patil, N.; Meng, R.; Bendell, J.; Cervantes, A.; Cho, B.
errShare
errSave
FOLFIRI ± napabucasin in patients with previously treated metastatic colorectal cancer: Overall survival results from the phase 3 CanStem303C study
err2021-07-01
err2
PREAI
errShah, M.; Yoshino, T.; Tebbutt, N.; Grothey, A.; Tabernero, J.; Xu, R.; Taieb, J.; Cervantes, A.; Oh, S.; Yamaguchi, K.; Fakih, M.; Falcone, A.; Wu, C.; Chiu, V.; Tomasek, J.; Bendell, J.; Fontaine, M.; Hitron, M.; Xu, B.; Van Cutsem, E.
errShare
errSave
Final overall survival for the phase 3 KN177 study: Pembrolizumab versus chemotherapy in microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer
err2021-07-01
err2
errOAAI
errAndre, T.; Shiu, K.; Kim, T.; Jensen, B.; Jensen, L.; Punt, C.; Smith, D.; Garcia-Carbonero, R.; Alcaide Garcia, J.; Gibbs, P.; De la Fouchardiere, C.; Rivera Herrero, F.; Elez, E.; Bendell, J.; Le, D.; Yoshino, T.; Zhong, W.; Fogelman, D.; Marinello, P.; Diaz, L., Jr.
errShare
errSave
A Phase I Study of an IDO-1 Inhibitor (LY3381916) as Monotherapy and in Combination With an Anti-PD-L1 Antibody (LY3300054) in Patients With Advanced Cancer
err2021-04-27
err15
PREAI
errKotecki, Nuria; Vuagnat, Perrine; O'Neil, Bert H.; Jalal, Shadia; Rottey, Sylvie; Prenen, Hans; Benhadji, Karim A.; Xia, Meng; Szpurka, Anna M.; Saha, Abhijoy; Wallin, Johan; Suriyapperuma, Subha; Galvao, Violeta R.; Geeganage, Sandaruwan; Doman, Thompson N.; Gandhi, Leena; Xu, Xiaojian; Bendell, Johanna
errShare
errSave
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial
err2021-04-06
err76
errOAAI
errMeyerhardt, Jeffrey A.; Shi, Qian; Fuchs, Charles S.; Meyer, Jeffrey; Niedzwiecki, Donna; Zemla, Tyler; Kumthekar, Priya; Guthrie, Katherine A.; Couture, Felix; Kuebler, Philip; Bendell, Johanna C.; Kumar, Pankaj; Lewis, Dequincy; Tan, Benjamin; Bertagnolli, Monica; Grothey, Axel; Hochster, Howard S.; Goldberg, Richard M.; Venook, Alan; Blanke, Charles; O'Reilly, Eileen M.; Shields, Anthony F.
errShare
errSave